JILITY Trademark

Trademark Overview


On Wednesday, June 14, 2017, a trademark application was filed for JILITY with the United States Patent and Trademark Office. The USPTO has given the JILITY trademark a serial number of 87488346. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 25, 2021. This trademark is owned by Eli Lilly and Company. The JILITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents a...
jility

General Information


Serial Number87488346
Word MarkJILITY
Filing DateWednesday, June 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 25, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 20, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, January 25, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 25, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 22, 2020EXTENSION 5 GRANTED
Wednesday, May 20, 2020EXTENSION 5 FILED
Wednesday, May 20, 2020TEAS EXTENSION RECEIVED
Wednesday, November 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2019EXTENSION 4 GRANTED
Monday, November 18, 2019EXTENSION 4 FILED
Monday, November 18, 2019TEAS EXTENSION RECEIVED
Wednesday, June 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2019EXTENSION 3 GRANTED
Monday, June 3, 2019EXTENSION 3 FILED
Monday, June 3, 2019TEAS EXTENSION RECEIVED
Tuesday, November 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 16, 2018EXTENSION 2 GRANTED
Friday, November 16, 2018EXTENSION 2 FILED
Friday, November 16, 2018TEAS EXTENSION RECEIVED
Thursday, June 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 6, 2018EXTENSION 1 GRANTED
Friday, June 1, 2018EXTENSION 1 FILED
Wednesday, June 6, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 1, 2018TEAS EXTENSION RECEIVED
Tuesday, December 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 14, 2017ASSIGNED TO EXAMINER
Tuesday, June 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 17, 2017NEW APPLICATION ENTERED IN TRAM